| Year |
Citation |
Score |
| 2019 |
Keenan KE, Biller JR, Delfino JG, Boss MA, Does MD, Evelhoch JL, Griswold MA, Gunter JL, Hinks RS, Hoffman SW, Kim G, Lattanzi R, Li X, Marinelli L, Metzger GJ, et al. Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs. Journal of Magnetic Resonance Imaging : Jmri. PMID 30680836 DOI: 10.1002/Jmri.26598 |
0.343 |
|
| 2019 |
Keenan KE, Biller JR, Boss MA, Peskin AP, Stupic KF, Russek SE, Delfino J, Does M, Evelhoch JL, Griswold M, Gunter J, Hinks RS, Hoffman S, Kim G, Lattanzi R, et al. Progress Towards Standards for Quantitative MRI (qMRI) and Outstanding Needs Journal of Magnetic Resonance Imaging. 49. DOI: 10.1002/Https://Doi.Org/10.1002/Jmri.26598 |
0.318 |
|
| 2018 |
Evelhoch JL. In vivo MR in the drug pipeline. Journal of Magnetic Resonance (San Diego, Calif. : 1997). PMID 29716831 DOI: 10.1016/J.Jmr.2018.04.012 |
0.312 |
|
| 2017 |
Keenan KE, Ainslie M, Barker AJ, Boss MA, Cecil KM, Charles C, Chenevert TL, Clarke L, Evelhoch JL, Finn P, Gembris D, Gunter JL, Hill DLG, Jack CR, Jackson EF, et al. Quantitative magnetic resonance imaging phantoms: A review and the need for a system phantom. Magnetic Resonance in Medicine. PMID 29083101 DOI: 10.1002/Mrm.26982 |
0.372 |
|
| 2016 |
Campbell BR, Gonzalez Trotter D, Hines CD, Li W, Patel M, Zhang W, Evelhoch JL. In Vivo Imaging in Pharmaceutical Development and Its Impact on the 3Rs. Ilar Journal. 57: 212-220. PMID 28053073 DOI: 10.1093/Ilar/Ilw019 |
0.319 |
|
| 2014 |
Seah S, Asad AB, Baumgartner R, Feng D, Williams DS, Manigbas E, Beaver JD, Reese T, Henry B, Evelhoch JL, Chin CL. Investigation of cross-species translatability of pharmacological MRI in awake nonhuman primate - a buprenorphine challenge study. Plos One. 9: e110432. PMID 25337714 DOI: 10.1371/Journal.Pone.0110432 |
0.344 |
|
| 2013 |
Becerra L, Upadhyay J, Chang PC, Bishop J, Anderson J, Baumgartner R, Schwarz AJ, Coimbra A, Wallin D, Nutile L, George E, Maier G, Sunkaraneni S, Iyengar S, Evelhoch JL, et al. Parallel buprenorphine phMRI responses in conscious rodents and healthy human subjects. The Journal of Pharmacology and Experimental Therapeutics. 345: 41-51. PMID 23370795 DOI: 10.1124/Jpet.112.201145 |
0.335 |
|
| 2013 |
Schmidt E, Blackman S, Iannone R, Senderak E, Railkar R, Evelhoch J, Mozley P, Perez E, McDonough M, Rimawi M, Tolaney S, Kim S, Chung H. Abstract P4-01-11: Limits of [18F]-FLT PET as a clinical biomarker of proliferation in breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P4-01-11 |
0.377 |
|
| 2011 |
Rossin R, Kohno T, Hagooly A, Sharp T, Gliniak B, Arroll T, Chen Q, Hewig A, Kaplan-Lefko P, Friberg G, Radinsky R, Evelhoch JL, Welch MJ, Hwang DR. Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 942-9. PMID 21571804 DOI: 10.2967/Jnumed.110.086157 |
0.335 |
|
| 2009 |
Herbst RS, Hong D, Chap L, Kurzrock R, Jackson E, Silverman JM, Rasmussen E, Sun YN, Zhong D, Hwang YC, Evelhoch JL, Oliner JD, Le N, Rosen LS. Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3557-65. PMID 19546406 DOI: 10.1200/Jco.2008.19.6683 |
0.332 |
|
| 2006 |
Arias-Mendoza F, Payne GS, Zakian KL, Schwarz AJ, Stubbs M, Stoyanova R, Ballon D, Howe FA, Koutcher JA, Leach MO, Griffiths JR, Heerschap A, Glickson JD, Nelson SJ, Evelhoch JL, et al. In vivo 31P MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial. Nmr in Biomedicine. 19: 504-12. PMID 16763965 DOI: 10.1002/Nbm.1057 |
0.345 |
|
| 2005 |
Evelhoch J, Garwood M, Vigneron D, Knopp M, Sullivan D, Menkens A, Clarke L, Liu G. Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. Cancer Research. 65: 7041-4. PMID 16103049 DOI: 10.1158/0008-5472.Can-05-0674 |
0.385 |
|
| 2005 |
Liu G, Rugo HS, Wilding G, McShane TM, Evelhoch JL, Ng C, Jackson E, Kelcz F, Yeh BM, Lee FT, Charnsangavej C, Park JW, Ashton EA, Steinfeldt HM, Pithavala YK, et al. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5464-73. PMID 16027440 DOI: 10.1200/Jco.2005.04.143 |
0.362 |
|
| 2005 |
Spees WM, Evelhoch JL, Thompson PA, Sloop DJ, Ackerman JJ. Defining the pHi-hyperthermia sensitivity relationship for the RIF-1 tumor in vivo: a 31P MR spectroscopy study. Radiation Research. 164: 86-99. PMID 15966768 DOI: 10.1667/Rr3390 |
0.377 |
|
| 2005 |
Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. British Journal of Cancer. 92: 1599-610. PMID 15870830 DOI: 10.1038/Sj.Bjc.6602550 |
0.35 |
|
| 2004 |
Arias-Mendoza F, Zakian K, Schwartz A, Howe FA, Koutcher JA, Leach MO, Griffiths JR, Heerschap A, Glickson JD, Nelson SJ, Evelhoch JL, Charles HC, Brown TR. Methodological standardization for a multi-institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies. Nmr in Biomedicine. 17: 382-91. PMID 15386624 DOI: 10.1002/Nbm.915 |
0.335 |
|
| 2004 |
Bezabeh T, Evelhoch JL, Sloop DJ, Ackerman JJ. Methodology for applied 4 MHz RF hyperthermia concomitant with 31P NMR spectroscopic monitoring of murine tumours. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 20: 637-45. PMID 15370819 DOI: 10.1080/0265673042000196478 |
0.337 |
|
| 2004 |
Evelhoch JL, LoRusso PM, He Z, DelProposto Z, Polin L, Corbett TH, Langmuir P, Wheeler C, Stone A, Leadbetter J, Ryan AJ, Blakey DC, Waterton JC. Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 3650-7. PMID 15173071 DOI: 10.1158/1078-0432.Ccr-03-0417 |
0.394 |
|
| 2003 |
Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson G, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin G, et al. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. The British Journal of Radiology. 76: S87-91. PMID 15456718 DOI: 10.1259/Bjr/15917261 |
0.322 |
|
| 2000 |
Evelhoch JL, Gillies RJ, Karczmar GS, Koutcher JA, Maxwell RJ, Nalcioglu O, Raghunand N, Ronen SM, Ross BD, Swartz HM. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia (New York, N.Y.). 2: 152-65. PMID 10933074 DOI: 10.1038/Sj.Neo.7900078 |
0.399 |
|
| 2000 |
Gillies RJ, Bhujwalla ZM, Evelhoch J, Garwood M, Neeman M, Robinson SP, Sotak CH, Van Der Sanden B. Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia (New York, N.Y.). 2: 139-51. PMID 10933073 DOI: 10.1038/Sj.Neo.7900076 |
0.4 |
|
| 2000 |
He Z, Evelhoch JL, Mohammad RM, Adsay NV, Pettit GR, Vaitkevicius VK, Sarkar FH. Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer Pancreas. 21: 69-76. PMID 10881935 DOI: 10.1097/00006676-200007000-00054 |
0.392 |
|
| 1999 |
Taylor JS, Tofts PS, Port R, Evelhoch JL, Knopp M, Reddick WE, Runge VM, Mayr N. MR imaging of tumor microcirculation: promise for the new millennium. Journal of Magnetic Resonance Imaging : Jmri. 10: 903-7. PMID 10581502 DOI: 10.1002/(Sici)1522-2586(199912)10:6<903::Aid-Jmri1>3.0.Co;2-A |
0.401 |
|
| 1999 |
Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology Journal of Magnetic Resonance Imaging. 10: 254-259. PMID 10508284 DOI: 10.1002/(Sici)1522-2586(199909)10:3<254::Aid-Jmri5>3.0.Co;2-9 |
0.348 |
|
| 1999 |
Simpson NE, Evelhoch JL. Deuterium NMR tissue perfusion measurements using the tracer uptake approach: II. Comparison with microspheres in tumors Magnetic Resonance in Medicine. 42: 240-247. PMID 10440948 DOI: 10.1002/(Sici)1522-2594(199908)42:2<240::Aid-Mrm5>3.0.Co;2-8 |
0.369 |
|
| 1999 |
Simpson NE, He Z, Evelhoch JL. Deuterium NMR tissue perfusion measurements using the tracer uptake approach: I. Optimization of methods Magnetic Resonance in Medicine. 42: 42-52. PMID 10398949 DOI: 10.1002/(Sici)1522-2594(199907)42:1<42::Aid-Mrm8>3.0.Co;2-Z |
0.315 |
|
| 1997 |
Resnick LM, Militianu D, Cunnings AJ, Pipe JG, Evelhoch JL, Soulen RL. Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension. 30: 654-9. PMID 9322999 DOI: 10.1161/01.Hyp.30.3.654 |
0.301 |
|
| 1997 |
Soulen RL, Romero JA, Chuba PJ, Evelhoch JL, Simpson RE, Forman JD. Musculoskeletal complications of neutron therapy for prostate cancer. Radiation Oncology Investigations. 5: 81-91. PMID 9303061 DOI: 10.1002/(Sici)1520-6823(1997)5:2<81::Aid-Roi6>3.0.Co;2-F |
0.321 |
|
| 1996 |
Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. Journal of Neurosurgery. 84: 449-58. PMID 8609557 DOI: 10.3171/Jns.1996.84.3.0449 |
0.361 |
|
| 1996 |
Zhao M, Pipe JG, Bonnett J, Evelhoch JL. Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo British Journal of Cancer. 73: 61-64. PMID 8554985 DOI: 10.1038/Bjc.1996.11 |
0.319 |
|
| 1995 |
Zhao M, Fortan LG, Evelhoch JL. The effects of isoflurane and halothane on blood flow and 31P NMR spectra in murine RIF‐1 tumors Magnetic Resonance in Medicine. 33: 610-618. PMID 7596264 DOI: 10.1002/Mrm.1910330505 |
0.332 |
|
| 1994 |
Leach MO, Arnold D, Brown TR, Charles HC, de Certaines JD, Evelhoch JL, Margulis AR, Negendank WG, Nelson SJ, Podo F. International Workshop on Standardization in Clinical Magnetic Resonance Spectroscopy Measurements: proceedings and recommendations. Academic Radiology. 1: 171-86. PMID 9419483 DOI: 10.1016/S1076-6332(05)80838-4 |
0.331 |
|
| 1992 |
Evelhoch JL, McDouall JBL, Mattiello J, Simpson NE. Measurement of relative regional tumor blood flow in mice by deuterium NMR imaging Magnetic Resonance in Medicine. 24: 42-52. PMID 1532621 DOI: 10.1002/Mrm.1910240105 |
0.355 |
|
| 1992 |
Evelhoch JL. Measurement of tumor blood flow by deuterium NMR and the effects of modifiers Nmr in Biomedicine. 5: 290-295. PMID 1449970 DOI: 10.1002/Nbm.1940050516 |
0.334 |
|
| 1991 |
Larcombe-Mcdouall JB, Mattiello J, McCoy CL, Simpson NE, Seyedsadr M, Evelhoch JL. Size dependence of regional blood flow in murine tumours using deuterium magnetic resonance imaging International Journal of Radiation Biology. 60: 109-113. PMID 1677956 DOI: 10.1080/09553009114551651 |
0.321 |
|
| 1991 |
Mattiello J, Evelhoch JL. Relative volume-average murine tumor blood flow measurement via deuterium nuclear magnetic resonance spectroscopy Magnetic Resonance in Medicine. 18: 320-334. PMID 1646371 DOI: 10.1002/Mrm.1910180207 |
0.356 |
|
| 1990 |
Mattiello J, Evelhoch JL, Brown E, Schaap AP, Hetzel FW. Effect of photodynamic therapy on RIF‐1 tumor metabolism and blood flow examined by 31P and 2H NMR spectroscopy Nmr in Biomedicine. 3: 64-70. PMID 2390455 DOI: 10.1002/Nbm.1940030204 |
0.324 |
|
| 1989 |
Evelhoch JL. In vivo19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism Investigational New Drugs. 7: 5-12. PMID 2661482 DOI: 10.1007/Bf00178187 |
0.379 |
|
| 1987 |
Evelhoch JL, Keller NA, Corbett TH. An examination of the specificity of in vivo 31P MRS adriamycin response markers Annals of the New York Academy of Sciences. 508: 426-428. DOI: 10.1111/J.1749-6632.1987.Tb32926.X |
0.304 |
|
| 1986 |
Evelhoch JL, Sapareto SA, Nussbaum GH, Ackerman JJ. Correlations between 31P NMR spectroscopy and 15O perfusion measurements in the RIF-1 murine tumor in vivo. Radiation Research. 106: 122-31. PMID 3961103 DOI: 10.2307/3576567 |
0.35 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, ... ... Evelhoch JL, et al. Imaging biomarker roadmap for cancer studies. Nature Reviews. Clinical Oncology. PMID 27725679 DOI: 10.1038/Nrclinonc.2016.162 |
0.299 |
|
| 2015 |
Sampath S, Klimas M, Feng D, Baumgartner R, Manigbas E, Liang AL, Evelhoch JL, Chin CL. Characterization of regional left ventricular function in nonhuman primates using magnetic resonance imaging biomarkers: a test-retest repeatability and inter-subject variability study. Plos One. 10: e0127947. PMID 26010607 DOI: 10.1371/Journal.Pone.0127947 |
0.299 |
|
| 2018 |
Lohith TG, Bennacef I, Vandenberghe R, Vandenbulcke M, Salinas-Valenzuela C, Declercq R, Reynders T, Telan-Choing F, Riffel K, Celen S, Serdons K, Bormans G, Tsai K, Walji A, Hostetler ED, ... Evelhoch JL, et al. First-in-human brain imaging of Alzheimer dementia patients and elderly controls with F-MK-6240, a PET tracer targeting neurofibrillary tangle pathology. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29880509 DOI: 10.2967/Jnumed.118.208215 |
0.297 |
|
| 2012 |
Iannone R, Evelhoch JL, Lam R, Bergstrom DA, Thornton B, Herman GA, Mozley PD. FDG-PET and CT as early predictors of outcome in NSCLC patients treated with erlotinib. Journal of Clinical Oncology. 30: 10573-10573. DOI: 10.1200/Jco.2012.30.15_Suppl.10573 |
0.296 |
|
| 1994 |
Leach MO, Arnold D, Brown TR, Charles HC, de Certaines JD, Evelhoch JL, Margulis AR, Negendank WG, Nelson SJ, Podo F. International workshop on standardization in clinical MRS measurements: proceedings and recommendations. Technology and Health Care : Official Journal of the European Society For Engineering and Medicine. 2: 217-34. PMID 7842307 DOI: 10.3233/Thc-1994-2402 |
0.294 |
|
| 2020 |
Sampath S, Parimal AS, Huang W, Manigbas E, Gsell W, Chang MML, Qiu A, Jacobsen K, Evelhoch JL, Chin CL. Quantification of regional myocardial mean intracellular water lifetime: A nonhuman primate study in myocardial stress. Nmr in Biomedicine. e4248. PMID 31977123 DOI: 10.1002/Nbm.4248 |
0.294 |
|
| 2012 |
Upadhyay J, Anderson J, Baumgartner R, Coimbra A, Schwarz AJ, Pendse G, Wallin D, Nutile L, Bishop J, George E, Elman I, Sunkaraneni S, Maier G, Iyengar S, Evelhoch JL, et al. Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine. Neuroimage. 59: 3762-73. PMID 22119647 DOI: 10.1016/J.Neuroimage.2011.11.034 |
0.293 |
|
| 2000 |
Resnick LM, Militianu D, Cunnings AJ, Pipe JG, Evelhoch JL, Soulen RL, Lester MA. Pulse waveform analysis of arterial compliance: relation to other techniques, age, and metabolic variables. American Journal of Hypertension. 13: 1243-9. PMID 11130766 DOI: 10.1016/S0895-7061(00)01219-X |
0.292 |
|
| 1996 |
Soto GE, Zhu Z, Evelhoch JL, Ackerman JJ. Tumor 31P NMR pH measurements in vivo: a comparison of inorganic phosphate and intracellular 2-deoxyglucose-6-phosphate as pHnmr indicators in murine radiation-induced fibrosarcoma-1. Magnetic Resonance in Medicine. 36: 698-704. PMID 8916020 DOI: 10.1002/Mrm.1910360508 |
0.291 |
|
| 2016 |
Sampath S, Parimal AS, Feng D, Chang MM, Baumgartner R, Klimas M, Jacobsen K, Manigbas E, Gsell W, Evelhoch JL, Chin CL. Quantitative MRI biomarkers to characterize regional left ventricular perfusion and function in nonhuman primates during dobutamine-induced stress: A reproducibility and reliability study. Journal of Magnetic Resonance Imaging : Jmri. PMID 27384520 DOI: 10.1002/Jmri.25379 |
0.289 |
|
| 2015 |
Zhao F, Holahan MA, Houghton AK, Hargreaves R, Evelhoch JL, Winkelmann CT, Williams DS. Functional imaging of olfaction by CBV fMRI in monkeys: insight into the role of olfactory bulb in habituation. Neuroimage. 106: 364-72. PMID 25498426 DOI: 10.1016/J.Neuroimage.2014.12.001 |
0.288 |
|
| 1984 |
Ackerman JJH, Evelhoch JL, Berkowitz BA, Kichura GM, Deuel RK, Lown KS. Selective suppression of the cranial bone resonance from 31P NMR experiments with rat brain in vivo Journal of Magnetic Resonance (1969). 56: 318-322. DOI: 10.1016/0022-2364(84)90109-4 |
0.287 |
|
| 2016 |
Bennacef I, Zeng Z, Lohith T, Miller PJ, Salinas CA, Connolly BM, Gantert LT, Hyking HD, Holahan MA, O’Malley SS, Purcell ML, Riffel K, Coleman PJ, Li J, Balsells-Padros J, ... ... Evelhoch J, et al. Discovery And First-In-Human Evaluation Of The Tau-Imaging Pet Radiotracer [18F]Mk-6240 Alzheimers & Dementia. 12: 136. DOI: 10.1016/J.Jalz.2016.06.218 |
0.286 |
|
| 2016 |
Walji AM, Hostetler ED, Selnick H, Zeng Z, Miller P, Bennacef I, Salinas C, Connolly B, Gantert L, Holahan M, O'Malley S, Purcell M, Riffel K, Li J, Balsells J, ... ... Evelhoch JL, et al. Discovery of 6-(fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([(18)F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs). Journal of Medicinal Chemistry. PMID 27088900 DOI: 10.1021/Acs.Jmedchem.6B00166 |
0.286 |
|
| 1990 |
Neve WD, Evelhoch J, Everett C, Simpson N, Bissery MC, Corbett T, Valeriote F. Interaction between flavone acetic acid (LM-975, NSC 349512) and radiation in Glasgow's osteogenic sarcoma in vivo. International Journal of Radiation Oncology Biology Physics. 18: 1359-1365. PMID 2370185 DOI: 10.1016/0360-3016(90)90309-8 |
0.286 |
|
| 2014 |
Zhao F, Williams M, Bowlby M, Houghton A, Hargreaves R, Evelhoch J, Williams DS. Qualification of fMRI as a biomarker for pain in anesthetized rats by comparison with behavioral response in conscious rats. Neuroimage. 84: 724-32. PMID 24064074 DOI: 10.1016/J.Neuroimage.2013.09.036 |
0.283 |
|
| 2016 |
Baumgartner R, Cho W, Coimbra A, Chen C, Wang Z, Struyk A, Venketasubramanian N, Low M, Gargano C, Zhao F, Williams D, Reese T, Seah S, Feng D, Apreleva S, ... ... Evelhoch JL, et al. Evaluation of an fMRI USPIO-based assay in healthy human volunteers. Journal of Magnetic Resonance Imaging : Jmri. PMID 27775841 DOI: 10.1002/Jmri.25499 |
0.283 |
|
| 2012 |
Zhao F, Welsh D, Williams M, Coimbra A, Urban MO, Hargreaves R, Evelhoch J, Williams DS. fMRI of pain processing in the brain: a within-animal comparative study of BOLD vs. CBV and noxious electrical vs. noxious mechanical stimulation in rat. Neuroimage. 59: 1168-79. PMID 21856430 DOI: 10.1016/J.Neuroimage.2011.08.002 |
0.282 |
|
| 2013 |
Hostetler ED, Joshi AD, Sanabria-Bohórquez S, Fan H, Zeng Z, Purcell M, Gantert L, Riffel K, Williams M, O'Malley S, Miller P, Selnick HG, Gallicchio SN, Bell IM, Salvatore CA, ... ... Evelhoch JL, et al. In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232. The Journal of Pharmacology and Experimental Therapeutics. 347: 478-86. PMID 23975906 DOI: 10.1124/Jpet.113.206458 |
0.28 |
|
| 1985 |
Evelhoch JL, Ewy CS, Siegfried BA, Ackerman JJ, Rice DW, Briggs RW. 31P spin-lattice relaxation times and resonance linewidths of rat tissue in vivo: dependence upon the static magnetic field strength. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2: 410-7. PMID 4094555 DOI: 10.1002/Mrm.1910020409 |
0.278 |
|
| 1999 |
Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. Journal of Magnetic Resonance Imaging : Jmri. 10: 223-32. PMID 10508281 DOI: 10.1002/(Sici)1522-2586(199909)10:3<223::Aid-Jmri2>3.0.Co;2-S |
0.276 |
|
| 1984 |
Evelhoch JL, Crowley MG, Ackerman JJH. Signal-to-noise optimization and observed volume localization with circular surface coils Journal of Magnetic Resonance (1969). 56: 110-124. DOI: 10.1016/0022-2364(84)90195-1 |
0.276 |
|
| 2020 |
Zhao F, Meng X, Lu S, Hyde LA, Kennedy ME, Houghton AK, Evelhoch JL, Hines CDG. fMRI study of olfactory processing in mice under three anesthesia protocols: Insight into the effect of ketamine on olfactory processing. Neuroimage. 116725. PMID 32173412 DOI: 10.1016/J.Neuroimage.2020.116725 |
0.275 |
|
| 1983 |
Evelhoch JL, Ackerman JJH. NMR T1 measurements in inhomogeneous B1 with surface coils Journal of Magnetic Resonance (1969). 53: 52-64. DOI: 10.1016/0022-2364(83)90069-0 |
0.275 |
|
| 2015 |
Upadhyay J, Lemme J, Anderson J, Bleakman D, Large T, Evelhoch JL, Hargreaves R, Borsook D, Becerra L. Test-retest reliability of evoked heat stimulation BOLD fMRI. Journal of Neuroscience Methods. PMID 26072245 DOI: 10.1016/J.Jneumeth.2015.06.001 |
0.273 |
|
| 2004 |
Resnick LM, Barbagallo M, Bardicef M, Bardicef O, Sorokin Y, Evelhoch J, Dominguez LJ, Mason BA, Cotton DB. Cellular-free magnesium depletion in brain and muscle of normal and preeclamptic pregnancy: A nuclear magnetic resonance spectroscopic study Hypertension. 44: 322-326. PMID 15262910 DOI: 10.1161/01.Hyp.0000137592.76535.8C |
0.269 |
|
| 2015 |
Cox CD, Hostetler ED, Flores BA, Evelhoch JL, Fan H, Gantert L, Holahan M, Eng W, Joshi A, McGaughey G, Meng X, Purcell M, Raheem IT, Riffel K, Yan Y, et al. Discovery of [(11)C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 26077491 DOI: 10.1016/J.Bmcl.2015.05.080 |
0.265 |
|
| 2011 |
Williams DS, McCracken PJ, Jayakar RY, Purcell ML, Mathers PD, Savitz AT, Szumiloski JL, Cabal A, Dardzinski BJ, Motzel SL, Hangartner TN, Hargreaves RJ, Evelhoch JL, Duong LT, Cook JJ. Head-to-head comparison of treatment effects of odanacatib to alendronate in the ovariectomized rhesus monkey: A longitudinal multi-modality imaging study Bone. 48. DOI: 10.1016/J.Bone.2011.03.468 |
0.265 |
|
| 2013 |
Williams DS, McCracken PJ, Purcell M, Pickarski M, Mathers PD, Savitz AT, Szumiloski J, Jayakar RY, Somayajula S, Krause S, Brown K, Winkelmann CT, Scott BB, Cook L, Motzel SL, ... ... Evelhoch JL, et al. Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate. Bone. 56: 489-96. PMID 23806798 DOI: 10.1016/J.Bone.2013.06.008 |
0.265 |
|
| 2015 |
Zhao F, Wang X, Zariwala HA, Uslaner JM, Houghton AK, Evelhoch JL, Williams DS, Winkelmann CT. fMRI study of olfaction in the olfactory bulb and high olfactory structures of rats: Insight into their roles in habituation. Neuroimage. PMID 26522425 DOI: 10.1016/J.Neuroimage.2015.10.080 |
0.263 |
|
| 2016 |
Hostetler ED, Walji AM, Zeng Z, Miller P, Bennacef I, Salinas C, Connolly B, Gantert L, Haley H, Holahan M, Purcell M, Riffel K, Lohith T, Coleman P, Soriano A, ... ... Evelhoch JL, et al. Preclinical characterization of 18F-MK-6240, a promising positron emission tomography (PET) tracer for in vivo quantification of human neurofibrillary tangles (NFTs). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27230925 DOI: 10.2967/Jnumed.115.171678 |
0.263 |
|
| 2017 |
Gonzalez Trotter DE, Meng X, McQuade P, Rubins D, Klimas M, Zhang Z, Connolly BM, Miller PJ, O'Malley SS, Lin SA, Getty KL, Fayadat-Dilman L, Liang L, Wahlberg E, Widmark O, ... ... Evelhoch JL, et al. In vivo Imaging of the Programmed Death Ligand 1 by (18)F Positron Emission Tomography. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28588151 DOI: 10.2967/Jnumed.117.191718 |
0.262 |
|
| 1987 |
Evelhoch JL, Keller NA, Corbett TH. Response-specific Adriamycin Sensitivity Markers Provided by in Vivo 31P Nuclear Magnetic Resonance Spectroscopy in Murine Mammary Adenocarcinomas Cancer Research. 47: 3396-3401. PMID 3581077 |
0.261 |
|
| 1985 |
Crowley MG, Evelhoch JL, Ackerman JJH. The surface-coil NMR receiver in the presence of homogeneous B1 excitation Journal of Magnetic Resonance (1969). 64: 20-31. DOI: 10.1016/0022-2364(85)90026-5 |
0.258 |
|
| 2013 |
Cabal A, Jayakar RY, Sardesai S, Phillips EA, Szumiloski J, Posavec DJ, Mathers PD, Savitz AT, Scott BB, Winkelmann CT, Motzel S, Cook L, Hargreaves R, Evelhoch JL, Dardzinski BJ, et al. High-resolution peripheral quantitative computed tomography and finite element analysis of bone strength at the distal radius in ovariectomized adult rhesus monkey demonstrate efficacy of odanacatib and differentiation from alendronate. Bone. 56: 497-505. PMID 23791777 DOI: 10.1016/J.Bone.2013.06.011 |
0.257 |
|
| 2015 |
Hostetler ED, Fan H, Joshi AD, Zeng Z, Eng W, Gantert L, Holahan M, Meng X, Miller P, O'Malley S, Purcell M, Riffel K, Salinas C, Williams M, Ma B, ... ... Evelhoch JL, et al. Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [(11)C]MK-8193. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 26596571 DOI: 10.1007/S11307-015-0910-0 |
0.255 |
|
| 1989 |
Evelhoch JL, McCoy CL, Giri BP. A method for direct in vivo measurement of drug concentrations from a single 2H NMR spectrum Magnetic Resonance in Medicine. 9: 402-410. PMID 2710006 DOI: 10.1002/Mrm.1910090313 |
0.252 |
|
| 1992 |
Negendank WG, Brown TR, Evelhoch JL, Griffiths JR, Liotta LA, Margulis AR, Morrisett JD, Ross BD, Shtern F. Proceedings of a National Cancer Institute workshop: MR spectroscopy and tumor cell biology. Radiology. 185: 875-83. PMID 1438779 DOI: 10.1148/radiology.185.3.1438779 |
0.251 |
|
| 2016 |
Asad AB, Seah S, Baumgartner R, Feng D, Jensen A, Manigbas E, Henry B, Houghton A, Evelhoch JL, Derbyshire SW, Chin CL. Distinct BOLD fMRI Responses of Capsaicin-Induced Thermal Sensation Reveal Pain-Related Brain Activation in Nonhuman Primates. Plos One. 11: e0156805. PMID 27309348 DOI: 10.1371/Journal.Pone.0156805 |
0.251 |
|
| 2018 |
Zhao F, Holahan MA, Wang X, Uslaner JM, Houghton AK, Evelhoch JL, Winkelmann CT, Hines CDG. fMRI study of the role of glutamate NMDA receptor in the olfactory processing in monkeys. Plos One. 13: e0198395. PMID 29870538 DOI: 10.1371/Journal.Pone.0198395 |
0.248 |
|
| 2012 |
Borsook D, Upadhyay J, Klimas M, Schwarz AJ, Coimbra A, Baumgartner R, George E, Potter WZ, Large T, Bleakman D, Evelhoch J, Iyengar S, Becerra L, Hargreaves RJ. Decision-making using fMRI in clinical drug development: revisiting NK-1 receptor antagonists for pain. Drug Discovery Today. 17: 964-73. PMID 22579743 DOI: 10.1016/J.Drudis.2012.05.004 |
0.241 |
|
| 1990 |
McDouall JBL, Evelhoch JL. Deuterium Nuclear Magnetic Resonance Imaging of Tracer Distribution in D20 Clearance Measurements of Tumor Blood Flow in Mice Cancer Research. 50: 363-369. PMID 2153050 |
0.239 |
|
| 1988 |
Evelhoch JL, Bissery MC, Chabot GG, Simpson NE, McCoy CL, Heilbrun LK, Corbett TH. Flavone Acetic Acid (NSC 347512)-induced Modulation of Murine Tumor Physiology Monitored by in Vivo Nuclear Magnetic Resonance Spectroscopy Cancer Research. 48: 4749-4755. PMID 3409216 |
0.238 |
|
| 2011 |
Sanabria-Bohorquez S, Hostetler E, Van Laere K, Koole M, Bormans G, Serdons K, de Hoon J, Vandenberghe R, Versijpt J, De Lepeleire I, Reynders T, Tamagnan G, Marek K, Seibyl J, Jennings D, ... ... Evelhoch J, et al. P2-035: Preliminary evaluation of the amyloid PET Radioligand [18F]MK-3328 in Alzheimer's Disease patients Alzheimer's & Dementia. 7: S319-S319. DOI: 10.1016/J.Jalz.2011.05.925 |
0.237 |
|
| 2017 |
Zeng Z, Miller PJ, Connolly BM, O’Malley SS, Lohith T, Bennacef I, Mulhearn J, Schenk DJ, Hesk D, Walji A, Sur C, Li W, Hostetler ED, Evelhoch J. In Vitro Binding Studies To Evaluate The Nft-Specificity Of [ 3 H]Mk-6240 And [ 3 H]Av-1451 Binding In Subcortical Regions Of The Human Ad Brain Alzheimers & Dementia. 13: 1278. DOI: 10.1016/J.Jalz.2017.06.1920 |
0.236 |
|
| 1996 |
Ackerman JJ, Soto GE, Spees WM, Zhu Z, Evelhoch JL. The NMR chemical shift pH measurement revisited: analysis of error and modeling of a pH dependent reference. Magnetic Resonance in Medicine. 36: 674-83. PMID 8916017 DOI: 10.1002/Mrm.1910360505 |
0.232 |
|
| 2017 |
Zhao F, Wang X, Zariwala HA, Uslaner JM, Houghton AK, Evelhoch JL, Hostetler E, Winkelmann CT, Hines CD. fMRI study of the role of glutamate NMDA receptor in the olfactory adaptation in rats: insights into cellular and molecular mechanisms of olfactory adaptation. Neuroimage. PMID 28163142 DOI: 10.1016/J.Neuroimage.2017.01.068 |
0.229 |
|
| 2021 |
Stupic KF, Ainslie M, Boss MA, Charles C, Dienstfrey AM, Evelhoch JL, Finn P, Gimbutas Z, Gunter JL, Hill DLG, Jack CR, Jackson EF, Karaulanov T, Keenan KE, Liu G, et al. A standard system phantom for magnetic resonance imaging. Magnetic Resonance in Medicine. PMID 33847012 DOI: 10.1002/mrm.28779 |
0.211 |
|
| 2005 |
Eckstein F, Charles HC, Buck RJ, Kraus VB, Remmers AE, Hudelmaier M, Wirth W, Evelhoch JL. Accuracy and precision of quantitative assessment of cartilage morphology by magnetic resonance imaging at 3.0T. Arthritis and Rheumatism. 52: 3132-6. PMID 16200592 DOI: 10.1002/Art.21348 |
0.203 |
|
| 2006 |
Ashton E, McShane T, Evelhoch J. Inter-operator variability in perfusion assessment of tumors in MRI using automated AIF detection. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 8: 451-8. PMID 16685877 DOI: 10.1007/11566465_56 |
0.201 |
|
| 2007 |
Eckstein F, Buck RJ, Wyman BT, Kotyk JJ, Le Graverand MP, Remmers AE, Evelhoch JL, Hudelmaier M, Charles HC. Quantitative imaging of cartilage morphology at 3.0 Tesla in the presence of gadopentate dimeglumine (Gd-DTPA). Magnetic Resonance in Medicine. 58: 402-6. PMID 17654593 DOI: 10.1002/mrm.21290 |
0.201 |
|
| 2008 |
Ashton E, Raunig D, Ng C, Kelcz F, McShane T, Evelhoch J. Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. Journal of Magnetic Resonance Imaging. 28: 791-796. PMID 18777526 DOI: 10.1002/Jmri.21472 |
0.195 |
|
| 2004 |
Bezabeh T, Evelhoch JL, Thompson P, Sloop DJ, Ackerman JJ. Therapeutic efficacy as predicted by quantitative assessment of murine RIF-1 tumour pH and phosphorous metabolite response during hyperthermia: an in vivo 31P NMR study. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 20: 335-57. PMID 15204517 DOI: 10.1080/0265673042000196469 |
0.193 |
|
| 2012 |
LoRusso PM, Boerner SA, Evelhoch JL. Reply to E.S. Wang et al Journal of Clinical Oncology. 30: 762-763. DOI: 10.1200/Jco.2011.39.6895 |
0.173 |
|
| 1989 |
Negendank WG, Crowley MG, Ryan JR, Keller NA, Evelhoch JL. Bone and soft-tissue lesions: Diagnosis with combined H-1 MR imaging and P-31 MR spectroscopy Radiology. 173: 181-188. PMID 2675183 |
0.173 |
|
| 1984 |
Evelhoch JL, Sapareto SA, Jick DE, Ackerman JJ. In vivo metabolic effects of hyperglycemia in murine radiation-induced fibrosarcoma: a 31P NMR investigation. Proceedings of the National Academy of Sciences of the United States of America. 81: 6496-500. PMID 6593711 |
0.172 |
|
| 2008 |
LoRusso PM, Gadgeel SM, Wozniak A, Barge AJ, Jones HK, DelProposto ZS, DeLuca PA, Evelhoch JL, Boerner SA, Wheeler C. Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors. Investigational New Drugs. 26: 159-67. PMID 18219445 DOI: 10.1007/s10637-008-9112-9 |
0.16 |
|
| 2001 |
Evelhoch JL. pH and therapy of human cancers Novartis Foundation Symposium. 240: 68-80. PMID 11727937 |
0.137 |
|
| 2011 |
Upadhyay J, Anderson J, Schwarz AJ, Coimbra A, Baumgartner R, Pendse G, George E, Nutile L, Wallin D, Bishop J, Neni S, Maier G, Iyengar S, Evelhoch JL, Bleakman D, et al. Imaging drugs with and without clinical analgesic efficacy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2659-73. PMID 21849979 DOI: 10.1038/Npp.2011.156 |
0.135 |
|
| 2023 |
Shuping JL, Matthews DC, Adamczuk K, Scott D, Rowe CC, Kreisl WC, Johnson SC, Lukic AS, Johnson KA, Rosa-Neto P, Andrews RD, Van Laere K, Cordes L, Ward L, Wilde CL, ... ... Evelhoch JL, et al. Development, initial validation, and application of a visual read method for [F]MK-6240 tau PET. Alzheimer's & Dementia (New York, N. Y.). 9: e12372. PMID 36873926 DOI: 10.1002/trc2.12372 |
0.127 |
|
| 2020 |
Bennacef I, Rubins D, Riffel K, Williams M, Posavec DJ, Holahan MA, Purcell ML, Haley HD, Wolf M, Stachel SJ, Lubbers LS, Wesolowski GA, Duong LT, Hamill TG, Evelhoch JL, et al. Preclinical Evaluation of [ C]L-235 as a Radioligand for PET Cathepsin K Imaging in Bone. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 33226657 DOI: 10.1002/jlcr.3896 |
0.126 |
|
| 2021 |
Clavijo Jordan V, Hines CDG, Gantert LT, Wang S, Conarello S, Preihs C, Chirayil S, Klimas M, Evelhoch JL, Sherry AD. Imaging Beta-Cell Function in the Pancreas of Non-Human Primates Using a Zinc-Sensitive MRI Contrast Agent. Frontiers in Endocrinology. 12: 641722. PMID 34122330 DOI: 10.3389/fendo.2021.641722 |
0.124 |
|
| 2003 |
Carson PL, Giger M, Welch MJ, Halpern H, Kurdziel K, Vannier M, Evelhoch JL, Gazelle GS, Seltzer SE, Judy P, Hendee WR, Bourland JD. Biomedical Imaging Research Opportunities Workshop: report and recommendations. Radiology. 229: 328-39. PMID 12925715 DOI: 10.1148/radiol.2292030807 |
0.114 |
|
| 2020 |
Rubins DJ, Meng X, McQuade P, Klimas M, Getty K, Lin SA, Connolly BM, O'Malley SS, Haley H, Purcell M, Gantert L, Holahan M, Lindgren J, Eklund P, Ekblad C, ... ... Evelhoch JL, et al. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1. Molecular Imaging and Biology. PMID 33098025 DOI: 10.1007/s11307-020-01544-2 |
0.102 |
|
| 1981 |
Evelhoch JL, Bocian DF, Sudmeier JL. Evidence for direct metal-nitrogen binding in aromatic sulfonamide complexes of cadmium(II)-substituted carbonic anhydrases by cadmium-113 nuclear magnetic resonance Biochemistry. 20: 4951-4954. PMID 6794601 DOI: 10.1021/Bi00520A022 |
0.094 |
|
| 2020 |
Li W, Wang Y, Rubins D, Bennacef I, Holahan M, Haley H, Purcell M, Gantert L, Hseih S, Judo M, Seghezzi W, Zhang S, van der Veen EL, Lub-de Hooge MN, de Vries EGE, ... Evelhoch JL, et al. PET/CT Imaging of Zr-N-sucDf-Pembrolizumab in Healthy Cynomolgus Monkeys. Molecular Imaging and Biology. PMID 33104972 DOI: 10.1007/s11307-020-01558-w |
0.09 |
|
| 2003 |
Vannier M, Evelhoch JL. Imaging modalities across spatial scales. Academic Radiology. 10: 890-4. PMID 12945925 DOI: 10.1016/S1076-6332(03)00061-8 |
0.084 |
|
| 1980 |
Jonsson NB, Tibell LA, Evelhoch JL, Bell SJ, Sudmeier JL. Cadmium-113 NMR of carbonic anhydrases: effect of pH, bicarbonate, and cyanide Proceedings of the National Academy of Sciences of the United States of America. 77: 3269-3272. PMID 6774333 |
0.073 |
|
| 1991 |
Negendank WG, Crowley MG, Ryan JR, Keller NA, Evelhoch JL. Authors' response Investigative Radiology. 26: 770. |
0.059 |
|
| 2008 |
Lorusso PM, Nebiyou Bekele B, Boerner SA, Davis DW, Evelhoch JL, Herbst RS. Phase 1 Trials Today The Molecular Basis of Cancer. 553-570. DOI: 10.1016/B978-141603703-3.10047-0 |
0.03 |
|
| 1985 |
Alameda GK, Evelhoch JL, Sudmeier JL, Birge RR. Characterization of the internal calcium(II) binding sites in dissolved insulin hexamer using europium(III) fluorescence. Biochemistry. 24: 1757-62. PMID 3890940 DOI: 10.1021/Bi00328A028 |
0.022 |
|
| 2006 |
Evelhoch JL. Editorial Nmr in Biomedicine. 19: 635. DOI: 10.1002/nbm.1103 |
0.01 |
|
| Hide low-probability matches. |